1. "2022"
Formats
  1. Journal Article (2449)
  2. Meeting Abstract (2196)
  3. Review (615)
  4. Editorial (363)
  5. Book Section (139)
  6. Correspondence (117)
  7. Guidelines (112)
  8. Research Letter (82)
  9. Miscellaneous (60)
  10. Conference Paper (29)
  11. Book Whole (6)
Groups
  1. Department of Medicine (2621)
  2. Solid Tumor Oncology Division (1573)
  3. Sloan Kettering Institute Postdocs (1364)
  4. GSK Faculty (1152)
  5. Surgery (1036)
  6. Hematologic Malignancies, Division of (964)

More Groups

People
  1. Miguel-Angel Perales (95)
  2. Alexander Drilon (85)
  3. Saad Usmani (83)
  4. Sergio Giralt (77)
  5. Marc Ladanyi (72)
  6. Gilles Salles (69)

More People

Years
  1. 2022 (6168)
Publications
  1. Journal of Clinical Oncology (520)
  2. Blood (319)
  3. Cancer Research (191)
  4. Annals of Oncology (158)
  5. Annals of Surgical Oncology (134)
  6. International Journal of Radiation Oncology, Biology, Physics (132)

More Publications

Publishers
  1. Elsevier Inc. (794)
  2. American Society of Clinical Oncology (583)
  3. Springer (440)
  4. Nature Publishing Group (379)
  5. American Society of Hematology (369)
  6. Oxford University Press (360)

More Publishers

Results (6168)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel infusion strategy to reduce major side effects caused by anti-GD2 monoclonal antibody naxitamab without affecting its pharmacokinetics
    Meeting Abstract

    Mora, J.; Varo, A.; Castañeda, A.; Chamorro, S.; Muñoz, J. P.; Gorostegui, M.; Celma, M. S.; Lopez, S.; Simao, M.; Perez-Jaume, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Surufatinib in US patients with soft tissue sarcoma
    Meeting Abstract

    Movva, S.; Spira, A. I.; Hamilton, E. P.; Wang, J. S.; Cohn, A. L.; Strauss, J. F.; Stacchiotti, S.; Tucci, C.; Kauh, J.; Nanda, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Market determinants of commercial prices for intravenous chemotherapy infusions
    Meeting Abstract

    Milligan, M.; Orav, E. J.; Mitchell, A. P.; Lam, M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Pharmaceutical industry payments to physicians for the promotion of cancer drugs
    Meeting Abstract

    Mitchell, A. P.; Mishra Meza, A.; Trivedi, N. U.; Bach, P. B.; Gonen, M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Quantification of methylation-specific cardiomyocyte cell-free DNA as an early marker of cardiotoxicity in patients with breast cancer receiving anthracyclines and trastuzumab
    Meeting Abstract

    Moore, Z. R.; Yu, A. F.; Liu, J.; Dang, C. T.; Oeffinger, K. C.; Steingart, R.; Schmitt, A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1b/2 study of TP-0903 and decitabine targeting mutant TP53 and/or complex karyotype in patients with untreated acute myeloid leukemia ≥ age 60 years: Phase 1b interim results
    Meeting Abstract

    Mims, A. S.; Huang, Y.; Eisenmann, E.; Buelow, D.; Swords, R. T.; Foster, M. C.; Lin, T. L.; Baer, M. R.; Kovacsovics, T.; Al-Mansour, Z.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of ERBB2-altered gallbladder cancer
    Meeting Abstract

    Mondaca, S.; Schultz, N.; Roa, J. C.; Walch, H. S.; Sepulveda, S.; Harding, J. J.; Yaqubie, A.; Garcia, P.; Aguayo, G.; Nervi, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Updated overall survival (OS) data from the phase 1b study of tebentafusp (tebe) as monotherapy or combination therapy with durvalumab (durva) and/or tremelimumab (treme) in metastatic cutaneous melanoma (mCM)
    Meeting Abstract

    Middleton, M. R.; Hamid, O.; Shoushtari, A. N.; Meier, F. E.; Bauer, T. M.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P.; Mauch, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Alliance A059102: A randomized phase II US intergroup study of CHO(E)P versus CC-486-CHO(E)P versus duvelisib-CHO(E)P in previously untreated, CD30-negative, peripheral T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Geyer, S. M.; Barta, S. K.; Amengual, J. E.; Dockter, T.; Wright, C.; Dinner, S.; Hsi, E. D.; Bartlett, N. L.; Horwitz, S. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save